CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.
May 11, 2014•2 min
GRACEcast Lung Cancer Video
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Last refreshed: ⓘ
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episodes
Why Do We Call Them "Small Cell Lung Cancer" and "Non-Small Cell Lung Cancer"?
Dr. Cathy Pietanza of Memorial Sloan Kettering explains how small cell lung cancer and non-small cell lung cancer are differentiated. February 2014.
May 08, 2014•1 min
Targeting the RAF Pathway in Lung Cancer
Dr. Charles Rudin of Memorial Sloan Kettering talks about RAF and other genetic mutations that play a role in the growth of lung cancer. February 2014.
May 07, 2014•4 min
Is It Possible to Test Lung Tumors Without Doing a Biopsy?
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute talks about exciting new developments which will allow oncologists to test patients' lung tumors without invasive biopsies. February 2014.
May 06, 2014•4 min
What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?
Dr. Charles Rudin of Memorial Sloan Kettering on how PARP inhibitors may benefit patients with small cell lung cancer. February 2014.
May 05, 2014•3 min
New Insights into Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering on the new avenues of research into the treatment of small cell lung cancer. February 2014.
May 04, 2014•2 min
In What Clinical Setting Should Immunotherapies Be Developed?
Dr. Charles Rudin of Memorial Sloan Kettering discusses immune therapies that show promise in fighting lung cancer. February 2014.
May 01, 2014•2 min
Maintenance Therapy in Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering on current and emerging treatments that are given to help keep small cell lung cancer from coming back after it has disappeared following initial therapy. February 2014.
Apr 17, 2014•2 min
LDE225 and Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering talks about a drug currently in clinical trials that may successfully treat small cell lung cancer. February 2014.
Apr 17, 2014•1 min
Is There a Silver Bullet for Small Cell Lung Cancer?
Dr. Cathy Pietanza of Memorial Sloan Kettering discusses potential areas of success in the treatment of small cell lung cancer. February 2014.
Apr 17, 2014•2 min
Advice for Newly Diagnosed Small Cell Lung Cancer Patients
Dr. Cathy Pietanza of Memorial Sloan Kettering offers suggestions for newly diagnosed small cell lung cancer patients. February 2014.
Apr 17, 2014•1 min
PARP Inhibitors in Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering talks about the role of PARP inhibitors in the treatment of small cell lung cancer. February 2014.
Apr 17, 2014•1 min
What's the Status and Potential Utility of Cabozantinib in Lung Cancer?
Dr. Heather Wakelee of Stanford University Medical Center discusses whether or not cabozantinib - a drug already approved for thyroid cancer - can help patients with lung cancer. February 2014.
Apr 17, 2014•3 min
MK-3475 and its Efficacy in Lung Cancer
Dr. Edward Garon discusses what researchers are learning about MK-3475, an immune therapy treatment currently in clinical trial. February 2014.
Apr 17, 2014•5 min
How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?
Dr. Edward Garon warns that it is still too early to compare which immune therapies will be more effective in treating lung cancer.February 2014.
Apr 17, 2014•3 min
Do you see PARP inhibitors as a single drug therapy or more in a combination setting?
Dr. Cathy Pietanza of Memorial Sloan Kettering discusses whether PARP treatments can be taken alone or if they must be taken with other drugs. February 2014.
Apr 17, 2014•44 sec
ALK Positive Lung Cancer Forum 2014: Repeat Biopsies
Why would an ALK lung cancer patient need a repeat biopsy? The doctors discuss the need for and frequency of repeat biopsies.
Apr 04, 2014•4 min
ALK Positive Lung Cancer Forum 2014: Next Generation ALK Inhibitors
Several new treatments for ALK positive lung cancer patients are on the horizon. In this video, the doctors discuss them while patients in the audience share some of their experiences with side effects on various treatments.
Apr 04, 2014•20 min
ALK Positive Lung Cancer Forum 2014: Disease Progression While on Xalkori
New treatments for ALK rearrangements are on the horizon. In this video, the doctors discuss how they determine whether or not they change treatments for their patients once they begin to show progression while on Xalkori (crizotinib).
Apr 04, 2014•6 min
ALK Positive Lung Cancer Forum 2014: Scanning for Progression
How often should ALK patients receive scans to determine if their disease has progressed in various parts of the body?
Apr 04, 2014•11 min
ALK Positive Lung Cancer Forum 2014: Risk of Flare After Stopping Targeted Therapy
The doctors discuss how patients can navigate the tricky waters of stopping therapy while avoiding painful and sometimes life-threatening flare.
Apr 04, 2014•4 min
ALK Positive Lung Cancer Forum 2014: Can I Pass ALK Onto My Children
ALK positive lung cancer typically shows up in people do not appear to be at high risk for the disease, so is this something that a lung cancer patient can pass on to his or her children? The doctors discuss what research shows on this issue.
Apr 04, 2014•3 min
ALK Positive Lung Cancer Forum 2014: Testing for ALK
Who should be tested for ALK? How is ALK tested and how reliable are the results? In this video, the doctors discuss several issues surrounding the issue of testing for ALK, including what the medical guidelines suggest for testing lung cancer patients.
Apr 04, 2014•10 min
ALK Positive Lung Cancer Forum 2014: Xalkori
Xalkori (crizotinib) was one of the fastest approved drugs in cancer treatment history because of its high efficacy levels in ALK positive lung cancer patients. In this video, the doctors discuss what took place as it raced to approval.
Apr 04, 2014•4 min
ALK Positive Lung Cancer Forum 2014: ALK Rearrangements in Lung Cancer
The doctors discuss the history of ALK in lung cancer treatments and what the ALK rearragement means for patients.
Apr 04, 2014•12 min
Squamous Lung Cancer Part 5, Q and A Session (video)
Dr. David Spigel, Sarah Cannon Cancer Center, answers audience questions about squamous lung cancer.
Dec 20, 2013•14 min
Squamous Lung Cancer, Part 4: Immunotherapy (video)
Dr. David Spigel, Sarah Cannon Cancer Center, describes current research in immunotherapy as treatment for squamous lung cancer.
Dec 10, 2013•7 min
Squamous Lung Cancer, Part 3: Treatment (video)
Dr. David Spigel, Sarah Cannon Cancer Center, outlines treatment options for squamous lung cancer.
Dec 08, 2013•13 min
Squamous Lung Cancer, Part 2: Genomic Testing (video)
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the importance of genomic testing in squamous lung cancer.
Dec 06, 2013•12 min
Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (video)
Dr. David Spigel, Sarah Cannon Cancer Center, describes the diagnosis, presentation and workup of squamous lung cancer.
Dec 02, 2013•15 min
For the best experience, listen in Metacast app for iOS or Android